These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 1216338)
1. Determination of the acetylator phenotype in a Northern Nigerian population. Fawcett IW; Gammon PT Tubercle; 1975 Sep; 56(3):199-201. PubMed ID: 1216338 [TBL] [Abstract][Full Text] [Related]
2. Acetylation of sulfamethazine in a Nigerian population. Eze LC; Obidoa O Biochem Genet; 1978 Dec; 16(11-12):1073-7. PubMed ID: 751642 [TBL] [Abstract][Full Text] [Related]
3. Determination of the isoniazid acetylator phenotype in a West African population. Salako LA; Aderounmu AF Tubercle; 1977 Jun; 58(2):109-12. PubMed ID: 878015 [TBL] [Abstract][Full Text] [Related]
4. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis. Singh SP; Pande JN; Khilnani GC; Kailash S Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742 [TBL] [Abstract][Full Text] [Related]
5. Effect of concomitant isoniazid administration on determination of acetylator phenotype by sulphadimidine. Zysset T; Peretti E Eur J Clin Pharmacol; 1986; 30(4):463-6. PubMed ID: 3743623 [TBL] [Abstract][Full Text] [Related]
6. Xenobiotic metabolism in idiopathic Parkinson's disease in Nigerian Africans. Igbokwe E; Ogunniyi AO; Osuntokun BO East Afr Med J; 1993 Dec; 70(12):807-9. PubMed ID: 8026358 [TBL] [Abstract][Full Text] [Related]
7. N-acetylation phenotyping with sulphadimidine in a Turkish population. Bozkurt A; Basci NE; Kalan S; Tuncer M; Kayaalp SO Eur J Clin Pharmacol; 1990; 38(1):53-6. PubMed ID: 2328748 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the sulphadimidine acetylator phenotyping test in patients with reduced renal function. Hall S Acta Med Scand; 1981; 209(6):505-7. PubMed ID: 7257867 [TBL] [Abstract][Full Text] [Related]
9. Kinetic discrimination of three sulfamethazine acetylation phenotypes. Chapron DJ; Kramer PA; Mercik SA Clin Pharmacol Ther; 1980 Jan; 27(1):104-13. PubMed ID: 7351110 [TBL] [Abstract][Full Text] [Related]
10. [The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis]. Ellard GA Rev Mal Respir; 1984; 1(4):207-19. PubMed ID: 6505358 [TBL] [Abstract][Full Text] [Related]
11. Possible optimization of sulphadimidine dosage for acetylator phenotyping. Hombhanje F Jpn J Pharmacol; 1991 Aug; 56(4):531-4. PubMed ID: 1744992 [TBL] [Abstract][Full Text] [Related]
12. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid. Ylitalo P; Auterinen L; Marttinen A; Koivula T Int J Clin Pharmacol Res; 1984; 4(2):141-4. PubMed ID: 6469440 [TBL] [Abstract][Full Text] [Related]
13. Relationship between acetylator phenotype and intensity of the hypoglycaemic effect of a suplhonamide preparation in children with insulin-dependent diabetes. Hadasová E; Brysová V; Utĕsený J; Macků M Bratisl Lek Listy; 1991 Dec; 92(12):609-14. PubMed ID: 1806177 [TBL] [Abstract][Full Text] [Related]